Immediate Impact
1 by Nobel laureates 6 from Science/Nature 58 standout
Citing Papers
Medications for Obesity
2024 Standout
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
2023 Standout
Works of Bahar Erar being referenced
Genetic Predisposition to Weight Loss and Regain With Lifestyle Intervention: Analyses From the Diabetes Prevention Program and the Look AHEAD Randomized Controlled Trials
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Bahar Erar | 151 | 83 | 62 | 68 | 15 | 372 | |
| K. P. Tercyak | 179 | 66 | 28 | 23 | 10 | 339 | |
| Cheryl Rivard | 212 | 63 | 19 | 74 | 27 | 426 | |
| Jasmine Khouja | 218 | 74 | 18 | 76 | 23 | 443 | |
| Angela Martinelli | 115 | 26 | 49 | 37 | 27 | 385 | |
| Paul Wileyto | 253 | 66 | 37 | 28 | 19 | 429 | |
| Wade K. Copeland | 87 | 65 | 61 | 7 | 15 | 394 | |
| Kay L. Wanke | 188 | 44 | 10 | 26 | 15 | 348 | |
| Sarah Adkins | 147 | 39 | 10 | 27 | 17 | 361 | |
| Cheryl E. Lopes | 119 | 31 | 19 | 13 | 9 | 371 | |
| Andrew A. Strasser | 271 | 94 | 4 | 63 | 11 | 356 |
All Works
Login with ORCID to disown or claim papers
Loading papers...